cbdMD Inc. (YCBD)

Name: cbdMD Inc. (YCBD) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: cbdMD Inc. (YCBD)

Stock Card

$0.52

$-0.24 (-31.66%)

As on 26-Aug-2026 16:00EDT

Market cap

$6 Mln

Revenue (TTM)

$21 Mln

P/E Ratio

2.2

P/B Ratio

0.7

Div. Yield

0 %

cbdMD (YCBD) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.51 High: 0.53

52 Week Range

Low: 0.47 High: 2.56

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.4 %
ROCE

-- %
Industry P/E

37.31
EV/EBITDA

63.9
Debt to Equity

0
Book Value

$--
EPS

$-0.3
Face value

--
Shares outstanding

11,205,045

9 Years Aggregate

CFO

$-71.91 Mln

EBITDA

$3.24 Mln

Net Profit

$-159.88 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
cbdMD (YCBD)	-61.5	--	-31.7	-26.2	-60.6	-76.7	--
BSE Sensex^*	-8.7	1.6	1.7	-4.3	6.0	6.7	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 26-Aug-2026 | *As on 27-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
cbdMD (YCBD)	-55.0	-63.6	-89.8	-79.0	-63.4	30.5	-26.9
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
cbdMD (YCBD)	0.5	5.7	20.9	-2.9	-8.4	-33.5	2.2	0.7
Amneal Pharmaceuticals Inc Class A (AMRX)	18.0	6,238.0	3,117.6	157.4	14.7	--	37.3	188.9
Axsome Therapeutics (AXSM)	207.2	10,883.2	776.6	-191.6	-17.6	-223.4	--	130.9
BridgeBio Pharma (BBIO)	79.4	15,932.7	691.8	-696.2	-89.1	--	--	123.7
Corcept Therapeutics (CORT)	119.8	13,215.0	830.8	54.9	3.2	8.1	271.7	18.7
Dr. Reddy's Laboratories - ADR	12.2	10,087.6	332,834.2	33,166.6	11.1	8.9	28.8	2.5
Elanco Animal Health (ELAN)	25.1	11,971.8	5,020.0	-199.0	1.6	-3	--	1.8
Ligand Pharmaceuticals (LGND)	287.9	5,707.4	290.5	197.2	82.5	19.9	29.6	5.9
Liquidia Technologies Inc (LQDA)	71.4	6,142.1	450.9	138.6	39.1	115.6	49	31.5
Twist Bioscience Corp (TWST)	150.1	9,129.6	431.8	-136.7	-30.8	-30.3	--	20.5

Shareholding Pattern

View Details

About cbdMD (YCBD)

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products in the United States and internationally. The company owns and operates various consumer hemp-based CBD brands. Its cbdMD brand products include oils, gummies, capsules,... soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. It also provides products for dogs and cats, including tinctures, chews, and topicals under the Paw CBD brand name; non-cannabinoid functional ingredients, such as functional mushrooms under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers, and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is based in Charlotte, North Carolina. Read more

Interim CEO, CFO & Principal Executive Officer

Mr. T. Ronan Kennedy
Interim CEO, CFO & Principal Executive Officer

Mr. T. Ronan Kennedy
Headquarters

Charlotte, NC
Website

https://www.cbdmd.com

FAQs for cbdMD (YCBD)

What is the current share price of cbdMD Inc (YCBD) Today?

The share price of cbdMD Inc (YCBD) is $0.52 (NYSE) as of 26-Aug-2026 16:00 EDT. cbdMD Inc (YCBD) has given a return of -60.56% in the last 3 years.

What is the current PB & PE ratio of cbdMD Inc (YCBD)?

The P/E ratio of cbdMD Inc (YCBD) is 2.21 times as on 21-Aug-2026, a 94 discount to its peers’ median range of 37.31 times.
The P/B ratio of cbdMD Inc (YCBD) is 0.69 times as on 21-Aug-2026, a 91 discount to its peers’ median range of 7.75 times.

PE & PB ratio at the end of financial year.